Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
This report is a health system assessment focused on HIV care services for Venezuelan migrants living in Peru. The assessment reviews secondary data sources; interviews with key informants, users, and professionals who are responsible for health facilities providing Antiretroviral Therapy (HF ART); observes visits to selected HF ART; and provides an overview of a self-administered survey to those responsible for HF ART in the country.
En este informe, LHSS evalúa la demanda de productos básicos para el VIH necesarios para brindar una cobertura adecuada a los venezolanos que viven con el VIH en Perú y analiza los sistemas de pronóstico existentes en el Ministerio de Salud para determinar su precisión en la adquisición y el seguimiento de la distribución de medicamentos clave para el VIH.
In this report, LHSS quantifies the demand for HIV commodities needed to provide adequate coverage for Venezuelans living with HIV in Peru and analyzes existing forecasting systems at the MOH to determine its accuracy in procuring and monitoring the distribution of key HIV drugs.
LHSS tiene como objetivo fortalecer la capacidad del Ministerio de Salud para garantizar la disponibilidad de productos para el VIH (ARV y dispositivos médicos) para la población migrante venezolana en Perú. Como parte de este esfuerzo, LHSS estimó la demanda de productos relacionados con el VIH relacionados con esta población, incluidos detalles como el tipo, la cantidad y el momento.
This report provides a summary of the results of the quantification of demand for HIV commodities for the Venezuelan migrant population in Peru. It includes the capabilities and limitations of the quantification model, its approach to quantification, and the sources used.
This communications strategy outlines how the LHSS team will support the private sector providers in implementing their communication plans.
The LHSS Jamaica Grants Strategy guides implementation of the grants-under-contract component of the LHSS Jamaica activity, with the goal of increasing the capacity of local organizations to prepare, obtain, and manage successful health systems strengthening projects and activities.
LHSS conducted this rapid assessment to better understand the current and potential role of the private health sector in Jamaica's COVID-19 response.
This brief explores ways in which digital tools and systems can be used successfully and responsibly to advance SBC interventions in support of health system strengthening, and provides recommendations for future programming and areas of research.
This report describes key private sector players and their types of engagement in malaria programming in Cote d’Ivoire, Democratic Republic of Congo, Liberia, and Uganda.
Conducted by LHSS, this market analysis examines four factors affecting SHI-covered ARV procurement and supply in Vietnam, and it also summarizes findings and recommendations across each of these factors.
LHSS shared the review of Timor-Leste’s thriving landscape of civil society organizations (CSOs), with a focus on those that are active in the health sector.
LHSS is supporting the Government of Jordan in institutionalizing CPD and developed this private sector engagement strategy to identify opportunities for engaging the private sector in the provision of CPD.
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.